JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nickola, T. J.
Right arrow Articles by Spengler, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nickola, T. J.
Right arrow Articles by Spengler, R. N.

Vol. 297, Issue 2, 680-687, May 2001

Antidepressant Drug-Induced Alterations in Neuron-Localized Tumor Necrosis Factor-alpha mRNA and alpha 2-Adrenergic Receptor Sensitivity

Tracey J. Nickola1, Tracey A. Ignatowski, Jessica L. Reynolds and Robert N. Spengler

State University of New York at Buffalo, Department of Pathology, School of Medicine and Biomedical Sciences, Buffalo, New York

The pleiotropic cytokine tumor necrosis factor-alpha (TNF) and alpha 2-adrenergic receptor activation regulate norepinephrine (NE) release from neurons in the central nervous system. The present study substantiates the role of TNF as a neuromodulator and demonstrates a reciprocally permissive relationship between the biological effects of TNF and alpha 2-adrenergic receptor activation as a mechanism of action of antidepressant drugs. Immunohistochemical analysis and in situ hybridization reveal that administration of the antidepressant drug desipramine decreases the accumulation of constitutively expressed TNF mRNA in neurons of the rat brain. Superfusion and electrical field stimulation were applied to a series of rat hippocampal brain slices to study the regulation of [3H]NE release. Superfusion of hippocampal slices obtained from rats chronically administered the antidepressant drug zimelidine demonstrates that TNF-mediated inhibition of [3H]NE release is transformed, such that [3H]NE release is potentiated in the presence of TNF, an effect that occurs in association with alpha 2-adrenergic receptor activation. However, chronic zimelidine administration does not alter stimulation-evoked [3H]NE release, whereas chronic desipramine administration increases stimulation-evoked [3H]NE release and concomitantly decreases alpha 2-adrenergic autoreceptor sensitivity. Collectively, these data support the hypothesis that chronic antidepressant drug administration alters alpha 2-adrenergic receptor-dependent regulation of NE release. Additionally, these data demonstrate that administration of dissimilar antidepressant drugs similarly transform alpha 2-adrenergic autoreceptors that are functionally associated with the neuromodulatory effects of TNF, suggesting a possible mechanism of action of antidepressant drugs.


1 This work is being submitted to the Graduate School of the State University of New York at Buffalo in partial fulfillment of the requirements for the Ph.D. degree in Pathology.


0022-3565/01/2972-0680$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
J. L. Reynolds, T. A. Ignatowski, R. Sud, and R. N. Spengler
Brain-Derived Tumor Necrosis Factor-{alpha} and Its Involvement in Noradrenergic Neuron Functioning Involved in the Mechanism of Action of an Antidepressant
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1216 - 1225.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.